The Ethics of Fecal Microbiota Transplant as a Tool for Antimicrobial Stewardship Programs

Area of Science:

• Microbiology
• Infectious Diseases
• Public Health

Background:

• Multidrug-resistant organisms (MDROs) pose a significant public health threat, diminishing antibiotic efficacy.
• Antimicrobial stewardship programs (ASPs) aim to curb antibiotic use to mitigate MDRO emergence.
• Fecal microbiota transplant (FMT) is explored as a strategy to reduce patient colonization by MDROs.

Purpose of the Study:

• To review the existing evidence and ethical considerations for expanding FMT utilization.
• To evaluate FMT's potential role in antimicrobial stewardship beyond its current indication.

Main Methods:

• Literature review of studies on FMT for MDROs.
• Analysis of ethical implications for expanded FMT use.
• Discussion of FMT's efficacy and safety in non-C. difficile infection contexts.

Main Results:

• Current evidence for FMT in reducing MDRO colonization is limited.
• Expanded FMT use requires robust clinical trial data.
• Ethical considerations include patient safety, informed consent, and resource allocation.

Conclusions:

• FMT shows promise for reducing MDRO colonization, but requires more research.
• ASPs may consider FMT for MDRO reduction, pending further evidence.
• Expanded clinical indications for FMT necessitate careful ethical and scientific evaluation.